Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07586995 · ClinicalTrials.gov registry record
A Post-Market Assessment of the Safety and Performance of the TriClip™ System
A clinical trial, sponsored by Abbott Medical Devices.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07586995: Recruiting study, sponsored by Abbott Medical Devices.
NCT07586995 is a clinical trial that is actively recruiting participants, run by Abbott Medical Devices. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07586995 is actively recruiting participants, sponsored by Abbott Medical Devices.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
Primary Outcome
Defined as all-cause mortality, device embolization, device thrombosis, non-elective surgery or transcatheter intervention for device- or procedure-related adverse event (AE) new pacemaker implantation and device- or procedure related major bleeding
Interventions
- DEVICE Tricuspid Transcatheter Edge-to-Edge Repair (TEER)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-06 |
| Est. Completion | 2033-08 |
What NCT07586995 shows while recruiting
NCT07586995 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Tricuspid Transcatheter Edge-to-Edge Repair (TEER) is the first listed.
NCT07586995 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07586995 about?
NCT07586995 is a clinical study titled "A Post-Market Assessment of the Safety and Performance of the TriClip™ System". The objective of the TREAT TR study is to confirm the safety and performance of the TriClip System for tricuspid TEER in a contemporary, real-world setting, using the commercially available device in accordance with its approved indications for use.
What is the current status of trial NCT07586995?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-06. Estimated completion is 2033-08.
What interventions are being tested in trial NCT07586995?
The interventions under investigation include: Tricuspid Transcatheter Edge-to-Edge Repair (TEER) (DEVICE).
Who is sponsoring clinical trial NCT07586995?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia